Related references
Note: Only part of the references are listed.Ovarian cancer tumor infiltrating T-regulatory (Treg) cells are associated with a metastatic phenotype
Jason C. Barnett et al.
GYNECOLOGIC ONCOLOGY (2010)
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
Ninke Leffers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer
Ninke Leffers et al.
GYNECOLOGIC ONCOLOGY (2009)
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer
Alain G. Zeimet et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Survival in Advanced Ovarian Cancer and Gene Expression Signature
[Anonymous]
GINECO RO (2009)
Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer
Anne P. G. Crijns et al.
PLOS MEDICINE (2009)
被撤回的出版物: The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation (Retracted article. See vol. 71, pg. 1196, 2011)
Joost Meijer et al.
CANCER RESEARCH (2008)
Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer
Michael J. Callahan et al.
CLINICAL CANCER RESEARCH (2008)
Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation
Ninke Leffers et al.
GYNECOLOGIC ONCOLOGY (2008)
Antigen-specific immunotherapy of cervical and ovarian cancer
Chien-Fu Hung et al.
IMMUNOLOGICAL REVIEWS (2008)
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells
Satoko Matsumura et al.
JOURNAL OF IMMUNOLOGY (2008)
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Ronald J. Buckanovich et al.
NATURE MEDICINE (2008)
SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-0-tetradecanoylphorbol-13-acetate-induced neoplastic transformation
Qingyang Gu et al.
CANCER RESEARCH (2007)
Statistically designing microarrays and microarray experiments to enhance sensitivity and specificity
Jason C. Hsu et al.
BRIEFINGS IN BIOINFORMATICS (2007)
Profiling studies in ovarian cancer: A review
Rudolf S. N. Fehrmann et al.
ONCOLOGIST (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Reliability and reproducibility issues in DNA microarray measurements
S Draghici et al.
TRENDS IN GENETICS (2006)
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy
APG Crijns et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Limitations of mRNA amplification from small-size cell samples
V Nygaard et al.
BMC GENOMICS (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Expression profiling of small cellular samples in cancer: less is more
JG Glanzer et al.
BRITISH JOURNAL OF CANCER (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Fundamentals of experimental design for cDNA microarrays
GA Churchill
NATURE GENETICS (2002)
Share Paper
